Insider Selling: Privia Health Group, Inc. (NASDAQ:PRVA) CFO Sells 2,320 Shares of Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 2,320 shares of the business’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total transaction of $42,734.40. Following the completion of the sale, the chief financial officer now owns 259,959 shares in the company, valued at approximately $4,788,444.78. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

David Mountcastle also recently made the following trade(s):

• On Tuesday, April 2nd, David Mountcastle sold 3,933 shares of Privia Health Group stock. The shares were sold at an average price of $17.77, for a total transaction of $69,889.41.

Privia Health Group Stock Up 2.1 %

NASDAQ PRVA traded up $0.38 during trading hours on Thursday, hitting $18.41. The company’s stock had a trading volume of 782,205 shares, compared to its average volume of 940,409. Privia Health Group, Inc. has a twelve month low of $17.54 and a twelve month high of $30.15. The firm has a market capitalization of $2.18 billion, a P/E ratio of 96.90, a PEG ratio of 2.51 and a beta of 0.81. The stock has a fifty day moving average of $19.67 and a 200 day moving average of $21.16.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Tuesday, February 27th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.02). Privia Health Group had a net margin of 1.39% and a return on equity of 3.97%. The business had revenue of $440.80 million for the quarter, compared to the consensus estimate of $425.81 million. During the same quarter in the previous year, the firm posted $0.14 EPS. The business’s revenue was up 21.0% on a year-over-year basis. On average, analysts predict that Privia Health Group, Inc. will post 0.26 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have weighed in on PRVA shares. Jefferies Financial Group began coverage on shares of Privia Health Group in a research note on Monday, February 26th. They set a “buy” rating and a $25.00 price objective on the stock. Canaccord Genuity Group dropped their price target on Privia Health Group from $41.00 to $37.00 and set a “buy” rating for the company in a report on Tuesday, March 19th. UBS Group reduced their price objective on Privia Health Group from $31.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, March 1st. Bank of America cut Privia Health Group from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $27.00 to $21.00 in a report on Thursday, February 22nd. Finally, Truist Financial cut their price target on Privia Health Group from $32.00 to $28.00 and set a “buy” rating for the company in a report on Thursday, February 29th. Two research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Privia Health Group has an average rating of “Moderate Buy” and an average target price of $27.62.

Hedge Funds Weigh In On Privia Health Group

Hedge funds have recently added to or reduced their stakes in the stock. Advisors Preferred LLC acquired a new position in shares of Privia Health Group during the 4th quarter worth about $2,137,000. Loomis Sayles & Co. L P boosted its stake in Privia Health Group by 1.2% during the 3rd quarter. Loomis Sayles & Co. L P now owns 623,870 shares of the company’s stock worth $14,349,000 after acquiring an additional 7,577 shares during the last quarter. Walleye Capital LLC bought a new position in Privia Health Group during the 3rd quarter worth approximately $1,394,000. Riverbridge Partners LLC grew its holdings in Privia Health Group by 8.7% during the fourth quarter. Riverbridge Partners LLC now owns 4,342,385 shares of the company’s stock valued at $100,005,000 after purchasing an additional 348,852 shares during the period. Finally, Vanguard Group Inc. increased its stake in Privia Health Group by 0.5% in the third quarter. Vanguard Group Inc. now owns 11,003,989 shares of the company’s stock valued at $253,092,000 after purchasing an additional 51,317 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.